Settled in East Lake High-tech Development Zone, the National Innovation Model Park, with innovation technology development support, Wuhan Hust Life Sci & Tech Co., Ltd. is continuously pursuing to be the top pharmaceutical manufacturer with technology advantage in the filed of polysaccharide, protein and other macromolecular Chemical API. HUST Life's production base of API, equipped with advanced specialized facilities for polymer drugs, has passed GMP of state FDA, which has become the biggest supplier of medium MW hydroxyethyl starch (HES) API in China, and an active advocate of "continuously improve quality standard of HES API".HUST Life has always been cooperating with HUST and National Nano Medicine Engineering Technology Research Center, who all granted HUST Life as their base for technology conversion, meanwhile, who offer strong technological support. The first industrialized API item-medium Molecular Weight HES 200/0.5, whose preparation is the main product of plasma substitute in current world, is the preferred remedy for curing and preventing hypovolemia and shock. During the cooperation with HUST, HUST Life has got four achievements in China: the first one to break through chemosynthesis technology of HES200/0.5; the first one to realize the industrialization of HES200/0.5; the top one to own international advanced technology; the first one to export HES200/0.5 & HES130/0.4. In 2009, HUST Life received first - class prize of Hubei Provincial Scientific and Technological Advances Award for its new synthesis technology of HES. So far, HUST Life has got registration certificate in 4 foreign countries and has exported its products to India, Bangladesh, South Korea, Russia, Ukraine, South America and other foreign countries, which means HUST Life has become the biggest manufacturer specialized in producing HES series.Persisting on the developing direction of polymer drug and the spirit of professional manufacturing, HUST Life achieved the series of medium MW hydroxyethyl starch in 2009, which enable itself to support different MW HES API like Pentastarch, Hetastarch and Tetrastarch. Furthermore HUST Life plans to expand its research in macromolecular iron supplement, Polysaccharides, and has accumulated a series of prospective polymer drugs projects for future development. With the enterprise culture "high efficiency, preciseness, truth-seeking & cooperation", depending on highly professional technology & management personnel, excellent manufacturing technology and superior quality, HUST Life bases itself on domestic market, faces international market, enhances the development, and is trying its best to contribute to the society.
